{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:48:03Z","timestamp":1778672883101,"version":"3.51.4"},"reference-count":35,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.3892\/etm.2017.4809","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T07:25:43Z","timestamp":1500449143000},"page":"2689-2694","source":"Crossref","is-referenced-by-count":16,"title":["Effects of telmisartan on improving leptin resistance and inhibiting hepatic fibrosis in rats with non-alcoholic fatty liver disease"],"prefix":"10.3892","volume":"14","author":[{"given":"Qiu-Zan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang-Mao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"key20180108135220_b1-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","article-title":"Epidemiology of nonalcoholic fatty liver disease in China","volume":"50","author":"Fan","year":"2009","journal-title":"J Hepatol"},{"key":"key20180108135220_b2-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO): EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"key20180108135220_b3-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: From steatos is to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"key20180108135220_b4-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Nonalcoholic fatty liver disease: The mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J Hepatol"},{"key":"key20180108135220_b5-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","article-title":"The natural history of nonalcoholic fatty liver: A follow-up study","volume":"22","author":"Teli","year":"1995","journal-title":"Hepatology"},{"key":"key20180108135220_b6-etm-0-0-4809","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20180108135220_b7-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"key20180108135220_b8-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000215181.60228.f7","article-title":"Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis","volume":"47","author":"Sugimoto","year":"2006","journal-title":"Hypertension"},{"key":"key20180108135220_b9-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3748\/wjg.v12.i2.322","article-title":"Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis","volume":"12","author":"Yokohama","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key20180108135220_b10-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3748\/wjg.15.942","article-title":"Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis","volume":"15","author":"Georgescu","year":"2009","journal-title":"World J Gastroenterol"},{"key":"key20180108135220_b11-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1478-3231.2009.02006.x","article-title":"Telmisartan attenuates progression of steatohepatitis in mice: Role of hepatic macrophage infiltration and effects on adipose tissue","volume":"29","author":"Kudo","year":"2009","journal-title":"Liver Int"},{"key":"key20180108135220_b12-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"key20180108135220_b13-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2174\/138161210791208884","article-title":"Leptin: The prototypic adipocytokine and its role in NAFLD","volume":"16","author":"Procaccini","year":"2010","journal-title":"Curr Pharm Des"},{"key":"key20180108135220_b14-etm-0-0-4809","first-page":"327","article-title":"Hepatic Fibrosis Study Group Of Chinese Liver Diseases Association: Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis","volume":"10","year":"2002","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20180108135220_b15-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108135220_b16-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"166","DOI":"10.15171\/mejdd.2016.29","article-title":"New concepts on pathogenesis and diagnosis of liver fibrosis; a review article","volume":"8","author":"Ebrahimi","year":"2016","journal-title":"Middle East J Dig Dis"},{"key":"key20180108135220_b17-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S1262-3636(08)74603-2","article-title":"Non-invasive diagnosis of steatosis and fibrosis","volume":"34","author":"Castera","year":"2008","journal-title":"Diabetes Metab"},{"key":"key20180108135220_b18-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"key20180108135220_b19-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"key":"key20180108135220_b20-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.23449","article-title":"Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver","volume":"51","author":"Thenappan","year":"2010","journal-title":"Hepatology"},{"key":"key20180108135220_b21-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: A narrative review","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"key20180108135220_b22-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1572-0241.2006.00848.x","article-title":"The evolving role of leptin and adiponectin in chronic liver diseases","volume":"101","author":"Tsochatzis","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key20180108135220_b23-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1210\/en.2010-0040","article-title":"Increased hepatic insulin sensitivity in mice lacking inhibitory leptin receptor signals","volume":"152","author":"Tom","year":"2011","journal-title":"Endocrinlolgy"},{"key":"key20180108135220_b24-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.bbadis.2013.05.012","article-title":"Fasting reduces liver fibrosis in a mouse model for chronic cholangiopathies","volume":"1832","author":"Sokolovi\u0107","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key20180108135220_b25-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.02.003","article-title":"Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK\/Stat, MAPK\/ERK and PI3K\/Akt signalling pathways in human ovarian cancer cell","volume":"210","author":"Ptak","year":"2012","journal-title":"Toxicol Lett"},{"key":"key20180108135220_b26-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jchemneu.2014.09.002","article-title":"Leptin and its receptors","volume":"61\u201362","author":"Wada","year":"2014","journal-title":"J Chem Neuroanat"},{"key":"key20180108135220_b27-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biocel.2012.12.019","article-title":"Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells","volume":"45","author":"Zhang","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180108135220_b28-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-800096-0.00002-0","article-title":"Biomarkers of liver fibrosis","volume":"62","author":"Suk","year":"2013","journal-title":"Adv Clin Chem"},{"key":"key20180108135220_b29-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/HJH.0b013e3280287a83","article-title":"Effects of telmisartan on fat distribution in individuals with the metabolic syndrome","volume":"25","author":"Shimabukuro","year":"2007","journal-title":"J Hypertension"},{"key":"key20180108135220_b30-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1291\/hypres.31.601","article-title":"Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro","volume":"31","author":"Yamada","year":"2008","journal-title":"Hypertens Res"},{"key":"key20180108135220_b31-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00441-011-1132-7","article-title":"Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation","volume":"344","author":"Kuwashiro","year":"2011","journal-title":"Cell Tissue Res"},{"key":"key20180108135220_b32-etm-0-0-4809","first-page":"281","article-title":"Effects of telmisartan on resistin expression in a rat model of nonalcoholic steatohepatitis and insulin resistance","volume":"23","author":"Zhang","year":"2015","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20180108135220_b33-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/1319-3767.173762","article-title":"Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial","volume":"22","author":"Alam","year":"2016","journal-title":"Saudi J Gastroenterol"},{"key":"key20180108135220_b34-etm-0-0-4809","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bbrc.2007.10.083","article-title":"Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet","volume":"364","author":"Jin","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108135220_b35-etm-0-0-4809","first-page":"477","article-title":"Prevention and regression of non-alcoholic steatohepatitis (NASH) in a rat model by metabosartan, telmisartan","volume":"26","author":"Nakagami","year":"2010","journal-title":"Int J Mol Med"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:21:27Z","timestamp":1515457287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.4809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,19]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.3892\/etm.2017.4809"],"URL":"https:\/\/doi.org\/10.3892\/etm.2017.4809","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}